Amwill Health Care Board of Directors

Get the latest insights into the leadership at Amwill Health Care. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Anshu AnshumanCompany secretary & compliance Officer
Tarun GandhiManaging Director
Anand GandhiManaging Director
Man Singh GilundiaNon Executive Independent Director
Vasanth KumarNon Executive Independent Director
Sapna ParmarNon Independent & Non Executive Director

Amwill Health Care Share price

AMWILL

33.49

1.76 (-4.99%)
Last updated on 23 Apr, 2026 | 15:12 IST
Today's High

36.00

Today's Low

33.49

52 Week Low

28.91

52 Week High

104.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Amwill Health Care FAQs

The board at Amwill Health Care consists of experienced professionals, including Anshu Anshuman, Tarun Gandhi, and others, overseeing the company’s strategic and corporate governance.

Directors at Amwill Health Care are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Anshu Anshuman is the current chairman at Amwill Health Care.

Executive directors at Amwill Health Care are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Amwill Health Care adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Amwill Health Care, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost